Components:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 29.04.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
In accordance with the statements in the “WARNING BOX”, the use of intramuscular Bacitracin (Maxilase Bacitracine) is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bacitracin (Maxilase Bacitracine) and other antibacterial drugs, Bacitracin (Maxilase Bacitracine) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Bacitracin (Maxilase Bacitracine) injection is an antibiotic that treats staph infection caused by a bacteria called staphylococcus (STAF-il-oh-KOK-us).
Bacitracin (Maxilase Bacitracine) injection is used in infants to treat pneumonia. It is also used to treat an infection that causes pus to build up between the lungs and the membrane that covers them.
Bacitracin (Maxilase Bacitracine) injection may also be used for purposes other than those listed in this medication guide.
Dosage Forms
Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product
Solution Reconstituted,
Intramuscular:
BACiiM: 50,000 units (1 ea)
Generic: 50,000 units (1 ea [DSC])
Solution Reconstituted,
Intramuscular [preservative free]:
BACiiM: 50,000 units (1 ea [DSC])
Generic: 50,000 units (1 ea)
Dosing: Pediatric
Note: In February 2020, the FDA requested that all current manufacturers of Bacitracin (Maxilase Bacitracine) for injection voluntarily withdraw their product from the market because other effective FDA-approved treatments are available that do not have the same serious risks as Bacitracin (Maxilase Bacitracine), including nephrotoxicity, anaphylactic reactions, and the need for repeated IM injections. This requested voluntary withdrawal does not impact approved topical or ophthalmic drugs that contain Bacitracin (Maxilase Bacitracine). Further information may be found at https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-Bacitracin (Maxilase Bacitracine)-injection-market.
Pneumonia and empyema; staphylococcal: Note: Due to toxicity risks, systemic use of Bacitracin (Maxilase Bacitracine) should be limited to situations where less toxic alternatives would not be effective; systemic use in pediatric patients is rare. Do not administer IV:
Infants: IM:
≤2.5 kg: 900 units/kg/day in 2 to 3 divided doses.
>2.5 kg: 1,000 units/kg/day in 2 to 3 divided doses.
See also:
What is the most important information I should know about Bacitracin (Maxilase Bacitracine)?
Before your child receives Bacitracin (Maxilase Bacitracine) injection, tell the doctor if the child has a history of kidney disease.
Many other drugs can damage the kidneys and should not be used together with Bacitracin (Maxilase Bacitracine). Tell your doctor if your child is receiving chemotherapy, medicines used to treat a bowel disorder, medications to prevent organ transplant rejection, antiviral medications, or any other injected antibiotics.
Get emergency medical help if your child has any of these signs of an allergic reaction: hives; difficulty breathing; swelling of the face, lips, tongue, or throat.
Serious side effects of Bacitracin (Maxilase Bacitracine) injection include urinating less than usual or not at all, blood in the urine, lower back pain, or painful urination.
Make sure your child receives this medication for the entire length of time prescribed by the doctor. Your child's symptoms may get better before the infection is completely treated. Bacitracin (Maxilase Bacitracine) injection will not treat a viral infection such as the common cold or flu.
Use Bacitracin (Maxilase Bacitracine) as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Bacitracin (Maxilase Bacitracine) may be used around the eye or in the eye. To use Bacitracin (Maxilase Bacitracine) in the eye, first, wash your hands. Using your index finger, pull the lower eyelid away from your eye to form a pouch. Squeeze a thin strip of ointment into the pouch. After using Bacitracin (Maxilase Bacitracine), gently close your eyes for 1 to 2 minutes. Wash your hands to remove any medicine that may be on them. Wipe the applicator tip with a clean, dry tissue.
- To prevent germs from contaminating your medicine, do not touch the applicator tip to any surface, including the eye. Keep the container tightly closed.
- Wash your hands before using Bacitracin (Maxilase Bacitracine). To use Bacitracin (Maxilase Bacitracine), pull the lower eyelid away from your eye to form a pouch. Squeeze a thin strip of ointment into the pouch. After using the medicine, gently close your eyes and keep them closed for 1 to 2 minutes. Wash your hands to remove any medicine that may be on them. Wipe the applicator tip with a clean, dry tissue.
- Ask your doctor how to use your contact lenses while using Bacitracin (Maxilase Bacitracine).
- Bacitracin (Maxilase Bacitracine) works best if it is used at the same time each day.
- To clear up your infection completely, use Bacitracin (Maxilase Bacitracine) for the full course of treatment. Keep using it even if you feel better in a few days.
- To prevent germs from contaminating your medicine, do not touch the applicator tip to any surface, including the eye. Keep the container tightly closed.
- If you miss a dose of Bacitracin (Maxilase Bacitracine), use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Bacitracin (Maxilase Bacitracine).
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.This medication is used to prevent and treat minor skin infections caused by small cuts, scrapes, or burns. It is available without a prescription for self-medication.
Do not use this product over large areas of the body. Ask your doctor first before using this product for serious skin injuries or infections (e.g., deep cuts, puncture wounds, animal bites, serious burns). A different treatment may be necessary for these types of conditions.
This product contains neomycin, Bacitracin (Maxilase Bacitracine), and polymyxin, antibiotics that work by stopping the growth of bacteria. This medication prevents/treats only bacterial skin infections. It will not work for other types of skin infections (e.g., infections caused by fungi, viruses). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How to use Bacitracin (Maxilase Bacitracine) topical
This medication is for use on the skin only. Follow all directions on the product package or use as directed by your doctor. If you have any questions, ask your doctor or pharmacist.
Clean and dry the affected skin area. If you are using the ointment, wash your hands first. Then apply a small amount of medication (no more than can fit on your finger tip) in a thin layer on the skin and rub in gently, usually 1 to 3 times a day. Wash your hands after applying the ointment. If you are using the spray, shake the container well before using, then spray a small amount on the affected area as directed, usually 1 to 3 times a day. You may cover small treatment areas with a sterile bandage.
Do not use large amounts of this medication or apply this more often or for a longer period than directed. Your condition will not clear faster, but the risk of side effects may be increased. Do not use this product for longer than 1 week unless directed by your doctor. Do not use this medication on irritated skin in a child's diaper area unless directed by the doctor. After applying the medication to the diaper area, do not use tight-fitting diapers or plastic pants.
Avoid getting this medication in your eyes or inside the nose or mouth. If this occurs, wipe off the medication and rinse thoroughly with water.
Use this medication regularly in order to get the most benefit from it. To help you remember, use it at the same time(s) each day.
If your condition does not improve after a few days or if it worsens, or if you think you may have a serious medical problem, seek immediate medical attention.
See also:
What other drugs will affect Bacitracin (Maxilase Bacitracine)?
BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). Avoid combination
BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). Monitor therapy
Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine. Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics. Avoid combination
Colistimethate: May enhance the nephrotoxic effect of Bacitracin (Maxilase Bacitracine) (Systemic). Avoid combination
Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. Monitor therapy
Neomycin: May enhance the nephrotoxic effect of Bacitracin (Maxilase Bacitracine) (Systemic). Avoid combination
Neuromuscular-Blocking Agents: Bacitracin (Maxilase Bacitracine) (Systemic) may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. Monitor therapy
Polymyxin B: May enhance the nephrotoxic effect of Bacitracin (Maxilase Bacitracine) (Systemic). Avoid combination
Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic. Consider therapy modification
Streptomycin: May enhance the nephrotoxic effect of Bacitracin (Maxilase Bacitracine) (Systemic). Avoid combination
See also:
What are the possible side effects of Bacitracin (Maxilase Bacitracine)?
Bacitracin (Maxilase Bacitracine) has such a low incidence of allergenicity that for all practical purposes side reactions are practically non-existent. However, if such reaction should occur, therapy should be discontinued.
To report SUSPECTED ADVERSE REACTIONS, contact Perrigo at 1-866-634-9120 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Bacitracin (Maxilase Bacitracine) is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. Its unique name derives from the fact that the bacillus producing it was first isolated in 1943 from a knee scrape from a girl named Margaret Tracy. As a toxic and difficult-to-use antibiotic, Bacitracin (Maxilase Bacitracine) doesn't work well orally. However, it is very effective topicallyacitracin Bacillus licheniformis is synthesised via the so-called nonribosomal peptide synthetases (NRPSs), which means that ribosomes are not involved in its synthesis.